HUHS015 is a potent PCA-1/ALKBH3 inhibitor both in vitro and in vivo. The bioavailability (BA) of HUHS015 was 7.2% in rats after oral administration. As expected, continuously administering HUHS015 significantly suppressed the growth of DU145 cells, which are human hormone-independent prostate cancer cells, in a mouse xenograft model without untoward effects.
For research use only. We do not sell to patients.
Name | HUHS015 |
---|---|
Iupac Chemical Name | 4-benzyl-3-methyl-1-(5-methyl-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-5-ol |
Synonyms | HUHS 015;HUHS-015 |
Molecular Formula | C19H18N4O |
Molecular Weight | 318.37242 |
Smile | C(C1=CC=CC=C1)C=1C(=NN(C1O)C1=NC2=C(N1)C=CC(=C2)C)C |
InChiKey | LFEFEOLVKXXVGD-UHFFFAOYSA-N |
InChi | InChI=1S/C19H18N4O/c1-12-8-9-16-17(10-12)21-19(20-16)23-18(24)15(13(2)22-23)11-14-6-4-3-5-7-14/h3-10,24H,11H2,1-2H3,(H,20,21) |
CAS Number | 1453097-13-6 |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Solid powder |
---|---|
Purity | 98% by HPLC |
Storage | -20 ºC for 3 years |
Solubility | Soluble in DMSO |
Handling | |
Shipping Condition | Shipped under ambient temperature |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |